Ischemia-modified albumin levels in patients with acute decompensated heart failure treated with dobutamine or levosimendan: IMA-HF study

OBJECTIVE: Ischemia-modified albumin (IMA) is a sensitive biomarker of myocardial ischemia. However, data on IMA levels in acute heart failure (HF) are still lacking. In this study, we aimed to evaluate serum IMA levels in acute decompensated HF and the effects of dobutamine and levosimendan treatme...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Anatol J Cardiol
Auteurs principaux: Çavuşoğlu, Yüksel, Korkmaz, Şule, Demirtaş, Selda, Gencer, Erkan, Şaşmaz, Hatice, Mutlu, Fezan, Güneş, Hakan, Mert, Uğur Kadir, Özdemir, Sedat, Kalaycı, Süleyman, Yılmaz, Mehmet Birhan
Format: Artigo
Langue:Inglês
Publié: Kare Publishing 2016
Sujets:
Original Investigation
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5336859/
https://ncbi.nlm.nih.gov/pubmed/26301344
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/akd.2015.6156
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires